BELLISAI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.722
EU - Europa 3.871
AS - Asia 2.357
SA - Sud America 358
AF - Africa 119
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 12.441
Nazione #
US - Stati Uniti d'America 5.642
RU - Federazione Russa 934
SG - Singapore 873
CN - Cina 742
GB - Regno Unito 696
IE - Irlanda 538
SE - Svezia 351
BR - Brasile 307
DE - Germania 290
UA - Ucraina 270
IT - Italia 246
FR - Francia 238
VN - Vietnam 210
HK - Hong Kong 176
FI - Finlandia 166
KR - Corea 99
IN - India 70
ZA - Sudafrica 53
CA - Canada 47
ES - Italia 36
BD - Bangladesh 27
IQ - Iraq 25
CI - Costa d'Avorio 20
JP - Giappone 19
PL - Polonia 18
AR - Argentina 17
MX - Messico 17
NL - Olanda 15
TR - Turchia 15
AT - Austria 14
BE - Belgio 13
CZ - Repubblica Ceca 13
PK - Pakistan 13
MA - Marocco 12
NG - Nigeria 12
IR - Iran 11
EC - Ecuador 10
UZ - Uzbekistan 10
AU - Australia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
IL - Israele 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
TN - Tunisia 6
CO - Colombia 5
DO - Repubblica Dominicana 5
JO - Giordania 5
KG - Kirghizistan 5
UY - Uruguay 5
BG - Bulgaria 4
EG - Egitto 4
GR - Grecia 4
PY - Paraguay 4
VE - Venezuela 4
JM - Giamaica 3
TW - Taiwan 3
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
IM - Isola di Man 2
KZ - Kazakistan 2
LB - Libano 2
OM - Oman 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
Totale 12.437
Città #
Dallas 926
Menlo Park 806
Singapore 609
Southend 599
Dublin 528
Ashburn 398
Fairfield 364
Chandler 293
Moscow 258
Santa Clara 256
Jacksonville 208
San Jose 201
Beijing 195
Woodbridge 180
Hong Kong 171
Houston 141
Wilmington 140
Seattle 134
Hefei 122
Ann Arbor 118
Cambridge 112
Princeton 99
Seoul 98
Helsinki 90
Los Angeles 88
The Dalles 88
New York 85
Munich 81
Nanjing 74
Ho Chi Minh City 72
Siena 60
Lauterbourg 56
Hanoi 47
Johannesburg 45
San Mateo 38
Boardman 37
Council Bluffs 36
Dearborn 35
Milan 31
Buffalo 30
São Paulo 30
Turku 26
Nanchang 25
Orem 24
San Diego 24
Shanghai 21
Abidjan 20
Frankfurt am Main 20
London 20
Chicago 18
Columbus 18
Düsseldorf 18
Tokyo 18
Málaga 17
Warsaw 17
Chennai 16
Stockholm 16
Bengaluru 15
Denver 15
Montreal 15
Shenyang 15
Brooklyn 14
Dong Ket 14
Hebei 14
San Francisco 14
Venezia 14
Washington 14
Brussels 13
Rio de Janeiro 13
Toronto 13
Abuja 12
Changsha 12
Florence 12
Jinan 12
Redondo Beach 12
Rome 12
Tianjin 12
Vienna 12
Atlanta 11
Guangzhou 11
Baghdad 10
Da Nang 10
Mumbai 9
Ningbo 9
Nuremberg 9
Phoenix 9
Tashkent 9
Belo Horizonte 8
Brno 8
Haiphong 8
Portsmouth 8
Fremont 7
Guayaquil 7
Kunming 7
Lappeenranta 7
Mexico City 7
Norwalk 7
Amsterdam 6
Jiaxing 6
Manchester 6
Totale 8.755
Nome #
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 350
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 294
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 291
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 291
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 286
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 285
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 284
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 284
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 280
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 280
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 269
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 259
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 256
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 250
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 246
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 245
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 245
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 243
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 239
Chromosome aberrations in Raynaud's phenomenon 237
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 235
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 234
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 225
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 225
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 212
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 211
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes 209
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 207
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 200
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 198
Anterior chest wall non-traumatic diseases: A road map for the radiologist 198
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 196
HCV e malattie autoimmuni 191
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 186
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 185
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 179
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 178
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm 177
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 176
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 175
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C 173
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 170
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 170
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection 166
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 165
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 160
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 160
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 157
Associazione interferon α2b e ciclosporina A nel trattamento dell'epatite cronica C: Trial controllato 155
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. 152
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 152
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 148
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 146
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. 142
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 140
La tipizzazione genetica nelle malattie reumatiche autoimmuni e nelle sindromi autoinflammatorie 131
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 129
Le indicazioni al trattamento con immunoglobuline endovena nella sindrome da anticorpi antifosfolipidi. [Indications for intra-venous immunoglobulins treatment in the antiphospholipid syndrome] 126
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 110
null 99
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease 91
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 88
Totale 12.541
Categoria #
all - tutte 36.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 44 60 68
2021/2022695 48 79 45 77 27 16 31 20 30 66 89 167
2022/20231.080 68 105 153 150 107 215 16 88 108 22 28 20
2023/2024845 37 16 77 79 28 232 280 9 3 10 11 63
2024/20251.741 35 90 203 82 228 94 66 87 124 82 218 432
2025/20264.467 338 612 760 558 1.055 243 482 89 131 199 0 0
Totale 12.541